Molecular Imaging and Radionuclide Therapy
1-4
Prognostic value of metabolic tumor volume measured by 18f-fdg PET/CT in esophageal cancer patients
Molecular Imaging and Radionuclide Therapy
ÇİĞDEM SOYDAL, CABİR YÜKSEL, Özlem N. KÜÇÜK, İlker ÖKTEN, ELGİN ÖZKAN, BEYZA DOĞANAY ERDOĞAN
In vitro evaluation of tc-99m radiopharmaceuticals for gastric emptying studies
Molecular Imaging and Radionuclide Therapy
Türkan ERTAY, Amet Semih DOĞAN, Özden ÜLKER, Hatice DURAK
Findings of bone scintigraphy after leech theraphy
Molecular Imaging and Radionuclide Therapy
Sinem ÖZYURT, GÖKHAN KOCA, Koray DEMİREL, Aylin BASKIN, Melike KORKMAZ
Imaging of primary liver carcinosarcoma scintigraphically; a case report
Molecular Imaging and Radionuclide Therapy
ÜMMÜHAN ABDÜLREZZAK, Mustafa KULA, Zeynep ERDOĞAN, AHMET TUTUŞ
Repeatability of the maximum standard uptake value (SUVmax) in FDG PET
Molecular Imaging and Radionuclide Therapy
Henry LINDHOLM, Johan STAAF, Hans JACOBSSON, Fredrik BROLIN, Robert HATHERLY, Alejandro SANCHEZ-CRESPO
False positive FDG PET/CT of recurrent testicular tumour due to orchitis
Molecular Imaging and Radionuclide Therapy
Robert MANSBERG, Bao HO, Chuong BUI
Testis scintigraphy in a patient with acute lymphoblastic leukemia
Molecular Imaging and Radionuclide Therapy
Mine EREN ŞENCAN, MURAT KOÇ, Hale ÖREN, Sermin ÖZKAL, Hatice DURAK
Molecular Imaging and Radionuclide Therapy
Nalan SELÇUK ALAN, AYŞEN FENERCİOĞLU, H. Hakan SELÇUK, Çağatay ULUÇAY, Esin YENCİLEK